Growth Metrics

Evaxion A (EVAX) Cash from Financing Activities (2020 - 2022)

Evaxion A posted quarterly Cash from Financing Activities of -$300000.0 for Q2 2022, down 101.19% year-on-year from $25.2 million in Q2 2021, and down 103.88% on a QoQ basis from $7.7 million in Q1 2022.

Evaxion A (EVAX) has 3 years of Cash from Financing Activities data on file, last reported at -$300000.0 in Q2 2022.

  • For the quarter ending Q2 2022, Cash from Financing Activities fell 101.19% year-over-year to -$300000.0; the trailing twelve-month figure through Jun 2022 stood at $57.8 million (up 1.64% YoY), and the FY2025 full-year result was $22.4 million, up 70.69% from the prior year.
  • Cash from Financing Activities for Q2 2022 stood at -$300000.0, down from $7.7 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $25.3 million in Q1 2021 and bottomed at -$300000.0 in Q2 2022.
  • The 3-year median for Cash from Financing Activities is $7.1 million (2020), against an average of $11.2 million.
  • The widest annual swing landed in 2021, when Cash from Financing Activities jumped 140388.89%; it then slumped 101.19% in 2022.
  • A 3-year view of Cash from Financing Activities shows it stood at $6.4 million in 2020, then jumped by 290.38% to $25.2 million in 2021, then plunged by 101.19% to -$300000.0 in 2022.
  • The last three Cash from Financing Activities figures came in at -$300000.0 (Q2 2022), $7.7 million (Q1 2022), and $25.2 million (Q3 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 7.00 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -600,000.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 53,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -538.80 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -802.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 15.71 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn - 238.74 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2022 -300,000.00
Jun 30, 2022 -300,000.00
Mar 31, 2022 7.74 Mn
Mar 31, 2022 7.74 Mn
Sep 30, 2021 25.15 Mn
Sep 30, 2021 25.15 Mn
Jun 30, 2021 25.22 Mn
Jun 30, 2021 25.22 Mn
Mar 31, 2021 25.25 Mn
Mar 31, 2021 25.25 Mn
Sep 30, 2020 6.44 Mn
Sep 30, 2020 6.44 Mn
Jun 30, 2020 -36,000.00
Jun 30, 2020 -36,000.00
Mar 31, 2020 -18,000.00
Mar 31, 2020 -18,000.00